Even though the application of FMT remains experimental, some studies show small benefits toward lowering depressive symptoms (Green et al., 2023)
A small 2018 study indicates that people with insulin resistance tend to have lower glutathione levels, particularly if they have experienced complications, such as neuropathy or retinopathy
Combining them in experimental models allows researchers to study synergistic effects on GH release pathways and receptor cross-talk
For topical use The risk-benefit ratio for topical copper peptides favors use for most people
Poor diet, illness, inactivity, and even aging deplete your glutathione stores
The astrocyte response in experimental portal-systemic encephalopathy: an electron microscopic study